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Summary: The binding of aluminium in rat serum was studied. Rats were loaded intraperitoneally with
different doses of aluminium(III)chloride 4 times during one week, before being killed by cardiac puncture.
One ml of serum was applied to a Sephacryl S-200 SF column and 70 fractions were collected. In the collected
fractions, the distribution of aluminium was measured and compared with the concentrations of total protein,
transferrin, and citrate.
The presence of a high molecular weight aluminium-complex in serum is confirmed. Although a possible role
for albumin cannot be excluded, it is most likely that transferrin plays a role as a carrier for biological
transport of aluminium in plasma. In addition to transferrin, aluminium was shown to be associated with
citrate in serum, resulting in a low-molecular weight complex. It is postulated that citrate acts as a chelator
for aluminium, and that the ΑΙ/citrate complex in serum may play an important role in intracellular
accumulation, and hence the toxicity, of aluminium.
Introduction
It is generally accepted that aluminium is the cause
of the dialysis-related diseases, microcytic anaemia,
vitamin D-resistant osteomalacia, and dialysis en-
cephalopathy (1—3). Controversial, however, is the
role of aluminium in the pathogenesis of some neu-
rological disorders such as Alzheimer's disease, amy-
otrophic lateral sclerosis, and Parkinsoni&n dementia
(4-7).
Mammalian toxicity of aluminium is dependent on
the bioavailability as well as on the chemical form of
the element. Although the chemical speciation of al-
uminium in serum may be essential for understanding
the (neuro-)toxic effects of this metal, little interest
has been given to this aspect. Speciation studies using
gel filtration chromatography, have indicated an as-
sociation of aluminium with albumin (8, 9) and trans-
ferrin (10 — 12). King and co-workers (8, 9), and Ber-
tholfand co-workers (13) also reported the association
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of aluminium with low-molecular weight serum con-
stituents. Furthermore, the ultrafiltrable low-molec-
ular weight fraction is reported to increase with the
total serum aluminium concentration (9, 14). The
existence of a low-molecular weight aluminium spe-
cies, however, has been challenged by others (10 — 12).
The aim of this investigation was, therefore, to ex-
amine the speciation of aluminium in rat serum in
relation to the total serum aluminium concentration,
using a study for calcium speciation as a methodo-
logical model (15).
Materials and Methods
Animals
Female Wistar rats weighing between 200 — 230 g were fed a
standard diet (Hope Farms, Linschoten, The Netherlands) with
tap water ad libitum (aluminium concentration less than 10
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The animals were given 4 intraperitoneal injections of 1 ml
each, consisting of physiological saline containing different
concentrations of aluminium (Aids χ 6H2O), on day 1, 3, 4,
and 7. The dosage scheme was thus chosen not to study a dose-
response relationship, but to achieve a range of serum concen-
trations. Therefore, two rats received a total dose of 0.8 mg
aluminium (1 mg per kg body weight every 48 h), another 2
rats 4 mg aluminium (5 mg/kg body weight every 48 h), and 2
rats 8 mg aluminium (10 mg/kg body weight weight every 48 h).
A control group of 4 rats received saline only. One rat receiving
5 mg/kg body weight died, so that the total number of animals
for further investigation amounted to 9.
On day 8, the animals were killed by cardiac puncture under
ether anaesthesia. Cardiac blood was collected with a 5-ml
syringe and allowed to clot in an aluminium-free polypropylene
tube (13 ml, 9.5 χ 1.6 cm, Sarstedt No. 55.518, Numbrecht,
W-Germany). After centrifugation at 4000 g for 15 min, serum
was separated and stored at —20 °C to be analysed later.
Gel f i l t ra t ion chromatography
Gel filtration was performed on a Pharmacia C-series column,
1.6 x 100 cm (Pharmacia Fine Chemicals No. 19-5104-01,
Uppsala, Sweden). Sephacryl S-200 SuperFine (Pharmacia Fine
Chemicals No. 17-0871-01, Uppsala, Sweden) was provided as
a ready-to-use slurry. The column was packed with the slurry
according to the manufacturer's manual.
The column eluent contained per litre: 140 mmol sodium (130
mmol NaCl, 6.8 mmol NaOH, and 3.0 mmol NaN3), 1.1 mmol
CaCl2, 0.50 mmol MgCl2, 4.0 mmol KC1, and 10 mmol tris-
(hydroxymethyl)-aminomethane (2-amino-2-hydroxymethyl-
1,3-propanediol, Fluka AG No. 93352, Buchs SG Switzerland)
adjusted to pH 7.40 ± 0.05 at 4 °C with 1 mol/1 HC1. Both
column and reservoir for the eluent were placed in a climate
chamber (4 °C). The flow rate was maintained with a Perkin
Elmer series 100 Pump (Perkin Elmer, Norwalk Conn., USA).
The eluent fractions were collected into aluminium-free poly-
propylene tubes using an automated fraction collector (LKB-
Producter AB 2211 SuperRac, Bromma, Sweden).
Calibration of the column was performed with a Pharmacia
calibration kit (Pharmacia Fine Chemicals No. 17-0442-01,
Uppsala, Sweden). Using blue dextran 2000, the void volume
(Vo) was found to be 56 ml. Using ribonuclease A (relative
molecular mass = 13700), chymotrypsinogen (Mr = 25000),
ovalbumin (Mr = 43 000), albumin (MT = 67 000), and aldolase
(Mr = 158 000) a calibration curve was determined and calcu-
lated:
Kav = -0.44 log (Mr) + 2.4 (r = 0.97).
One ml of serum was applied to the gel bed, and elution was
started at a flow rate of 0.41 ml/min. After elution of the void
volume, collection of the fractions was started. Seventy frac-
tions of 1.4 ml each were collected per run in polypropylene
tubes and stored at 4 °C to be analysed later.
Atomic absorption spectrophotometry
Aluminium in eluent and serum was analysed by electrothermal
atomic absorption spectrophotometry (Perkin Elmer 2380 and
HGA 500 graphite furnace, Perkin Elmer, Norwalk, Conn.,
USA). Pyrolytically coated graphite tubes (Perkin Elmer, No.
091504) were used. An aluminium hollow cathode lamp (Perkin
Elmer) was operated at 25 mA. Atomic absorption was meas-
ured at 309.3 nm, with a spectral band width of 0.7 nm.
The analysis of aluminium in serum has been described previ-
ously (16). For the determination of aluminium in the eluent
the procedure was modified. Standard solutions containing 0,
20, 50, 100, 150, and 200 μg/l aluminium were prepared in 2 g/1
Triton-XlOO with 83.3 ml/1 eluent. Samples were diluted 1:12
in 2 g/1 Triton-XlOO. A Perkin Elmer AS-40 model autosampler
was used to inject 20 μΐ volumes of standard solutions and
samples. All aluminium analyses, both in serum and eluent,
were performed in duplicate according to a previously described
furnace program (16). The within-day precision of the alumin-
ium assay in the eluent was established at 5.8% (100 μg/l;
η = 10), the day-to-day precision at 6.8% (100 μg/l; η = 6),
and the detection limit at 2 μg/l.
Analys is of total prote in , t r ans fe r r in , and citrate
Total protein was determined spectrophotometrically (Perkin
Elmer 552 Norwalk, Conn., USA) with a standard Bio-Rad
Microprotein Assay (17). Standards containing 0, 1,2, 5, and
10 mg/1 bovine serum albumin were used.
Transferrin in the eluent was analysed by Laurell "rocket"
immunoelectrophoresis (18), using a LKB 2117 Multiphor
(LKB-Producter AB, Bromma, Sweden). The agarose (LKB-
Producter AB No. 2206-101, Bromma, Sweden), containing
1.5% rabbit anti-transferrin serum, was prepared according to
the manufacturer's manual. The electrophoresis was run with
20 volts per cm and at 10 °C for 6 h. A series of 5 standards
(0.05, 0.1, 0.2, 0.4, and 0.5 g transferrin per 1) was applied to
each plate. After electrophoresis the gel was placed in 0.2 mol/1
NaCl until the following day, when it was stained with amido
black and dried.
Citrate was determined spectrophotometrically (Perkin Elmer
552, Perkin Elmer, Norwalk, Conn., USA) by a standard en-
zymatic technique (19). Standards containing 0, 20, 40, 50, 60,
80, and 100 μιηοΐ/ΐ Na-citrate were used.
Statistical procedures
Pearson's correlation coefficients were calculated for the rela-
tion between the serum aluminium concentration and the alu-
minium/transferrin molar ratio, the serum aluminium concen-
tration and the aluminium/citrate molar ratio, and the alumin-
ium/transferrin molar ratio and the aluminium/citrate molar
ratio. A partial correlation coefficient, correcting for serum
aluminium concentration, was also calculated for the alumin-
ium/transferrin molar ratio and the aluminium/citrate molar
ratio (20).
One-sided t-tests were used to examine the hypotheses that true
correlations were zero. Results with a p < 0.05 were considered
significant.
Results
Elution pattern
Gel filtration chromatography was performed with
sera of 9 (4 non-treated and 5 aluminium-treated) rats
containing low (less than 1 μηιοΐ/ΐ), intermediate (be-
tween 1 and 4 μπιοΐ/ΐ), and high (more than 4 μτηοΙ/1)
concentrations of aluminium. The elution pattern of
all sera on the Sephacryl S 200 SF-Column showed
two major aluminium peaks. The first aluminium
peak co-eluted with protein in fractions 12 to 29 (Mr
between 112000 and 32000), with a maximum in
fraction 20. The second major aluminium peak eluted
in fractions 53 to 68 (Afr < 10000), with a maximum
in fractions 58 — 62. The presence of transferrin (Mr
= 81000) (21) was demonstrated in fractions 12 to
26, with a maximum in fractions 20 — 21. In fractions
55 to 65 the presence of citrate was observed, with a
maximum in fractions 59 — 60 (fig. 1 and 2).
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Fig. 1. Elution pattern of 1 ml rat serum containing a low
concentration of aluminium (0.44 μηιοΐ/l) on a Sephac-
ryl S-200 SF column.
The solid line in the upper part of the figure represents
the aluminium concentration (in μηιοΐ/l), whereas the
dotted line represents the protein concentration (in mg/1)
in the elution fractions. In the lower part, however, the
solid line represents the transferrin concentration (in
μηιοΐ/l), whereas the dotted line represents the citrate
concentration (in μιηοΐ/ΐ) in the fractions.
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Fig. 2. Elution pattern of 1 ml rat serum containing a high
concentration of aluminium (14.0 μηιοΐ/l) on a Sephac-
ryl S-200 SF column.
The solid line in the upper part of the figure represents
the aluminium concentration (in μηιοΐ/l), whereas the
dotted line represents the protein concentration (in mg/1)
in the elution fractions. In the lower part, however, the
solid line represents the transferrin concentration (in
μιηοΐ/ΐ), whereas the dotted line represents the citrate
concentration (in μηιοΐ/ΐ) in the fractions.
Transferrin and citrate associated aluminium
For those fractions where a simultaneous elution of
aluminium and transferrin was detected, the molar
ratio of aluminium to transferrin was calculated. An
aluminium to citrate molar ratio was determined for
those fractions where a co-elution of aluminium and
citrate was observed (tab. 1).
Tab. 1. Relation between serum aluminium concentration and
the aluminium/transferrin and aluminium/citrate molar
ratio.
Aluminium concen-
tration in serum
Ounol/1)
0.26
0.44
0.44
0.82
1.78
2.67
9.41
9.48
14.0
Aluminium/trans-
ferrin molar
ratio
0.339
0.326
0.189
0.347
0.350
0.334
0.079
0.223
0.260
Aluminium/
citrate molar
ratio
0.120
0.081
0.100
0.110
0.140
0.141
0.102
0.096
0.151
A correlation coefficient of r = —0.54 (p = 0.03) was
obtained for the relation between the serum alumin-
ium concentration and the aluminium/transferrin mo-
lar ratio; the correlation coefficient for the serum
aluminium concentration and the aluminium/citrate
molar ratio was r = 0.27 (p = 0.12).
A correlation coefficient of 0.33 (p = 0.10) was com-
puted for the relation between the aluminium/trans-
ferrin molar ratio and the aluminium/citrate molar
ratio. However, the partial correlation coefficient be-
tween aluminium/transferrin and the aluminium/ci-
trate molar ratio was r = 0.59 (p = 0.03).
Discussion
Gel filtration chromatography with rat sera was per-
formed under equilibrium conditions with respect to
temperature, osmolarity, and pH. The sera, contain-
ing different concentrations of aluminium (ranging
from 0.44 to 14.0 μηιοΐ/ΐ), were collected after the rats
had been loaded intraperitoneally with aluminium.
The elution profiles of sera showed two major alu-
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minimum peaks: one co-eluted with protein (MT be-
tween 112000 and 32000), while the other co-eluted
with low-molecular weight serum constituents (MT
< 10 000). The separating capacity of the column was
restricted to compounds with a relative molecular
mass between 200000 and 10000. High-molecular
mass proteins, such as macroglobulin, immunoglob-
ulin M, and orosomucoid were eluted in the void
volume. As these proteins were not separated, their
respective association with aluminium could not be
studied in the present investigation.
The presence of transferrin was demonstrated in the
protein peak co-eluting with aluminium. This is con-
sistent with findings of others (10 — 12), and supports
the view that transferrin may act as a carrier for
aluminium in plasma (22, 23). The negative correla-
tion coefficient for the relation between the serum
aluminium concentration and the aluminium/trans-
ferrin molar ratio (r = —0.54; p = 0.03) suggests that
the relative amount of aluminium bound to transfer-
rin decreases when the serum aluminium concentra-
tion increases. Increased co-elution of free aluminium
in the transferrin fractions from sera with a high
aluminium concentration may explain this contradic-
tory finding. The resolution of the column used in
this study, however, was insufficiently high to exclude
a possible aluminium-binding role for other proteins,
especially albumin (Mr = 67000).
The second aluminium peak co-eluted with low-mo-
lecular weight serum constituents (MT < 10000). Al-
though ultrafiltration studies indicated that part of
aluminium in serum is non-protein bound and ultra-
filtrable (12, 14, 24), co-elution of aluminium with
low-molecular weight serum constituents has only
been detected in some gel filtration studies (8, 9, 13),
while in other studies, using other types of gel, no
association of aluminium with low-molecular weight
species was found (10 — 12).
Although citrate has often been nominated on theo-
retical or indirect grounds as a low-molecular weight
binder for aluminium in plasma, association of alu-
minium with citrate has never been demonstrated
before. The present finding strongly supports the pos-
tulated action of citrate as a chelator for aluminium
in plasma (23, 25 — 27).
In addition, based upon recent reports on the effect
of citrate on the intestinal absorption of aluminium
(28), and on the accumulation of aluminium in bone
and brain (29, 30), it is most likely that the passage
of aluminium through the cell membrane is markedly
increased when complexed to citrate. The aluminium/
citrate complex might therefore be of paramount im-
portance for the intracellular accumulation of alu-
minium.
The ultrafiltrable aluminium fraction is reported to
increase with the total serum aluminium concentra-
tion (9, 14). For the aluminium/citrate molar ratio,
however, this could not be confirmed in the present
study. This ratio appeared not to depend on the serum
aluminium concentration (r = 0.37; p = 0.10).
Application of partial correlation calculations re-
vealed that the aluminium/transferrin and the alu-
minium/citrate molar ratios are significantly corre-
lated (p = 0.03). This observation suggests an asso-
ciation between transferrin and citrate in the binding
of aluminium ions in plasma; and it supports the view
that the behaviour of aluminium in plasma is very
similar to that of iron (III), in which citrate acts as a
chelator and the iron/citrate complex reacts with
transferrin to form the transport complex (31).
Regarding the fraction of serum aluminium which co-
eluted with both transferrin and citrate, it was cal-
culated that, on average, only 21% (SD = 2.5%);
n = 9) of the total amount of aluminium recovered
in 70 fractions was found in the transferrin peak, and
that only 23% (SD = 8.2%; n = 9) of the aluminium
co-eluted with citrate. The recovery in the 70 fractions,
however, was greater than the quantity of aluminium
in the serum applied to the gel column. Contamina-
tion of the eluent with aluminium may be responsible
for this. The aluminium/transferrin molar ratio was
generally larger than the aluminium/citrate molar ra-
tio (tab. 1), confirming that the affinity of aluminium
for transferrin is greater than for citrate (23).
In conclusion, the observations of others that trans-
ferrin plays a role in the binding and transport of
aluminium in serum was confirmed in this study. A
comparable role for other proteins like albumin could,
however, not be excluded.
In addition to transferrin, aluminium was shown to
be associated with citrate in serum, resulting in a low-
molecular weight complex. In view of other studies in
which citrate was shown to enhance aluminium trans-
port in tissue, it may be assumed that the aluminium/
citrate complex in serum may play an important role
in the intracellular accumulation, and hence toxicity,
of aluminium.
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